Finally, we followed the expression levels of the ALOX12 gene in bone marrow aspirates from nine patients with MDS, CMML, and AML-MRC before and after/during AZA treatment in our hospital (Figure 5A). This evidence concerns the gene CD200 and myelodysplastic syndrome.